149 related articles for article (PubMed ID: 2095917)
1. Defining the mechanisms of transformation through analysis of revertant cells.
Bassin RH; Benade LE
Immunol Ser; 1990; 51():15-47. PubMed ID: 2095917
[No Abstract] [Full Text] [Related]
2. Reversion and rereversion in ras-transformed cells.
Marshall CJ
Immunol Ser; 1990; 51():89-106. PubMed ID: 2128917
[No Abstract] [Full Text] [Related]
3. Regulated expression of retroviruses and their oncogenes: models for tumor suppression.
Wyke J; Poole CJ
Immunol Ser; 1990; 51():49-73. PubMed ID: 1965702
[No Abstract] [Full Text] [Related]
4. Molecular mechanisms of malignant conversion in skin carcinogenesis.
Yuspa SH; Greenhalgh DA
Princess Takamatsu Symp; 1989; 20():281-8. PubMed ID: 2518687
[TBL] [Abstract][Full Text] [Related]
5. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
6. The interplay between ras oncogenes and tumor suppressor genes in experimental carcinogenesis.
Balmain A; Brown K; Bremner R
Immunol Ser; 1990; 51():75-88. PubMed ID: 2128916
[No Abstract] [Full Text] [Related]
7. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
[TBL] [Abstract][Full Text] [Related]
8. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression.
Tan RS; Taniguchi T; Harada H
Cancer Res; 1996 May; 56(10):2417-21. PubMed ID: 8625321
[TBL] [Abstract][Full Text] [Related]
9. Oncogenes and their mechanisms of action.
Găldean D
Roum Arch Microbiol Immunol; 1992; 51(1-2):75-99. PubMed ID: 1457825
[No Abstract] [Full Text] [Related]
10. trans-Dominant suppressor mutations of the H-ras oncogene.
Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
[TBL] [Abstract][Full Text] [Related]
11. Cellular genes possibly involved in the transformation process of the human melanoma cell line XP44 RO (Mel).
Lafarge-Frayssinet C; Daya-Grosjean L; Estrade S; Frezouls G; Sarasin A; Cassingena R
Anticancer Res; 1995; 15(4):1205-13. PubMed ID: 7654000
[TBL] [Abstract][Full Text] [Related]
12. Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells.
Huber BE; Cordingley MG
Oncogene; 1988 Sep; 3(3):245-56. PubMed ID: 3060790
[TBL] [Abstract][Full Text] [Related]
13. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
14. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
16. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
17. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
Woo RA; Poon RY
Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
[TBL] [Abstract][Full Text] [Related]
18. Genetic interaction between Rb and N-ras: differentiation control and metastasis.
Takahashi C; Ewen ME
Cancer Res; 2006 Oct; 66(19):9345-8. PubMed ID: 17018584
[TBL] [Abstract][Full Text] [Related]
19. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of tumours derived from rasV12/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development.
Vasseur S; Malicet C; Calvo EL; Dagorn JC; Iovanna JL
Mol Cancer; 2005 Jan; 4(1):4. PubMed ID: 15651998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
